Wird geladen...
Precision medicine in lupus nephritis: can biomarkers get us there?
Patients with systemic lupus erythematosus (SLE) frequently develop lupus nephritis (LN), a condition that can lead to end stage kidney disease (ESKD). Multiple serum and urine biomarkers for LN have been proposed in recent years, yet none have become incorporated into clinical use. The majority of...
Gespeichert in:
| Veröffentlicht in: | Transl Res |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6415919/ https://ncbi.nlm.nih.gov/pubmed/30179587 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trsl.2018.08.002 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|